About HealthAI Central
The Intelligence Hub for Health AI
We track the companies, capital, research, and policy shaping the future of AI-powered healthcare — so you don't have to.
106+
Companies Tracked
19
Coverage Categories
Daily
Editorial Updates
Free
Core Access
Our Mission
Artificial intelligence is transforming every corner of healthcare — from how drugs are discovered to how clinicians document patient encounters, from how radiology reads are interpreted to how health systems manage population risk. The pace of change is extraordinary, and the signal-to-noise ratio in most coverage is poor.
HealthAI Central exists to fix that. We are an independent editorial platform built for the professionals who need to stay ahead of this market: clinicians evaluating AI tools, investors tracking the competitive landscape, executives making build-vs-buy decisions, and policy professionals monitoring the regulatory environment.
We combine daily news coverage with a continuously updated company intelligence database — giving our readers both the narrative context and the structured data they need to make informed decisions.
What We Cover
Our editorial team covers the full spectrum of health AI — from foundational infrastructure to clinical deployment.
Breaking News & Analysis
Daily coverage of FDA clearances, clinical trial results, regulatory developments, and market-moving announcements across the health AI landscape.
Company Intelligence
Detailed profiles on 106+ health AI companies — funding history, leadership, technology focus, and competitive positioning across 19 categories.
Funding & M&A
Comprehensive tracking of venture rounds, strategic acquisitions, and IPO activity — with context on what each deal means for the broader market.
Policy & Regulation
Expert analysis of FDA guidance, CMS reimbursement policy, EU AI Act implications, and state-level regulatory developments affecting health AI deployment.
Drug Discovery & Research
Coverage of AI-driven drug discovery milestones, clinical trial design innovations, and the companies transforming pharmaceutical R&D timelines.
Opinion & Analysis
In-depth perspectives from clinicians, technologists, and policy experts on the strategic, ethical, and operational dimensions of health AI adoption.
Editorial Principles
Independence
Our editorial decisions are made independently of commercial relationships. Sponsored content is clearly labeled and never influences our news coverage or company assessments.
Accuracy
Every factual claim is sourced and verified. We correct errors promptly and transparently. When we get something wrong, we say so.
Depth over volume
We prioritize context and analysis over raw throughput. A story worth covering is worth covering well — with the background, implications, and expert perspective that busy professionals need.
Accessibility
Health AI is consequential for patients, clinicians, and society. We write for informed professionals without requiring a PhD in machine learning to follow along.
Stay Ahead of Health AI
Free access includes our daily news feed and company directory. Pro membership unlocks unlimited articles, full company profiles, exclusive research reports, and priority event access.
Get in Touch
Press & Editorial
Media inquiries, news tips, corrections, and press requests
press@healthaicentral.com